Cohort profile update: the Johns Hopkins HIV clinical cohort, 1989-2023

Catherine R Lesko1, Anthony T Fojo2, Jeanne C Keruly2

  • 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Baltimore, MD, 21205, USA. clesko2@jhu.edu.

PubMed

Insights

The Johns Hopkins HIV Clinical Cohort tracks over 8000 adults with HIV in Baltimore, adapting data collection over 30 years to study evolving patient needs and HIV care outcomes.

Area of Science:

  • Clinical Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • The Johns Hopkins HIV Clinical Cohort, established in 1989, provides longitudinal data on adults with HIV.
  • It captures comprehensive clinical information, patient-reported outcomes, and biological specimens.

Purpose of the Study:

  • To update the profile of the Johns Hopkins HIV Clinical Cohort.
  • To illustrate changes in the HIV-positive population in Baltimore over three decades.
  • To demonstrate adaptations in data collection to address evolving research needs in HIV care.

Main Methods:

  • Longitudinal data collection from electronic medical records.
  • Inclusion of patient-reported outcomes via standardized instruments.
  • Collection of plasma and peripheral blood mononuclear cells for a specimen repository.
  • Analysis of demographic and clinical data reflecting the Baltimore HIV epidemic.

Main Results:

  • The cohort has enrolled over 8000 individuals since 1989.
  • In 2021, the median age was 57, with 64% male, 77% non-Hispanic Black, and 37% with HIV acquired through injection drug use.
  • The cohort's demographics reflect the HIV epidemic in Baltimore over 30 years.

Conclusions:

  • The Johns Hopkins HIV Clinical Cohort remains a vital resource for understanding HIV care.
  • The cohort's evolution demonstrates responsiveness to changes in the HIV epidemic and patient characteristics.
  • Adaptations ensure continued relevance in addressing research gaps in HIV and substance use care.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
2.0K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.3K
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
709
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
97